Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma

New anticancer drugs that target oncogenic signaling molecules have greatly improved the treatment of certain cancers. However, resistance to targeted therapeutics is a major clinical problem and the redundancy of oncogenic signaling pathways provides back-up mechanisms that allow cancer cells to es...

Descripción completa

Detalles Bibliográficos
Autores principales: Schatz, Jonathan H., Oricchio, Elisa, Wolfe, Andrew L., Jiang, Man, Linkov, Irina, Maragulia, Jocelyn, Shi, Weiji, Zhang, Zhigang, Rajasekhar, Vinagolu K., Pagano, Nen C., Porco, John A., Teruya-Feldstein, Julie, Rosen, Neal, Zelenetz, Andrew D., Pelletier, Jerry, Wendel, Hans-Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2011
Materias:
Brief Definitive Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171093/
https://www.ncbi.nlm.nih.gov/pubmed/21859846
http://dx.doi.org/10.1084/jem.20110846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171093/
https://www.ncbi.nlm.nih.gov/pubmed/21859846
http://dx.doi.org/10.1084/jem.20110846

Ejemplares similares